Research & Development



  兩千五百將士隨著自家曲長進了早就修建好的軍營休息,于是,雲瑯高高的點將台下,又變得空空蕩蕩。   曹襄笑道︰“曹氏今後不再隨便舉薦什麼賢良了,除非是真的賢良,讓我覺得不推舉一下都對不起舅舅您的那種賢良。”很很撸在线视频   “馬面牆?這是什麼東西?”caoliu草榴社区|1024caoliu最新社区2017|caoliu草榴社区最新地址   這四十七封有問題的奏折中,比雲瑯事件還要大的就足足有十三件之多。   紅袖笑道︰“聶伯伯不會害我的。”一级毛片   偏偏,張安世等人通過別的渠道得知,渾邪王手中的黃金,並不比富貴城藏金少多少。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo